N@N

Joseph Stringer Reiterated (VIR) at Strong Buy and Held Target at $32 on, Apr 19th, 2023

Joseph Stringer of Needham, Reiterated "Vir Biotechnology, Inc." (VIR) at Strong Buy and Held Target at $32 on, Apr 19th, 2023.

Joseph has made no other calls on VIR in the last 4 months.

There are 6 other peers that have a rating on VIR. Out of the 6 peers that are also analyzing VIR, 2 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Michelle Gilson of "Morgan Stanley" Maintained at Hold with Increased Target to $27 on, Tuesday, April 4th, 2023
• Michael Ulz of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $30 on, Friday, January 27th, 2023

These are the ratings of the 4 analyists that currently disagree with Joseph

---

• Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $100 on, Monday, March 6th, 2023
• Eric Joseph of "JP Morgan" Upgraded from Hold to Buy and Decreased Target to $34 on, Monday, March 6th, 2023
• Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $53 on, Thursday, February 23rd, 2023
• Roanna Ruiz of "SVB Leerink" Maintained at Buy with Decreased Target to $43 on, Friday, January 27th, 2023

Contributing Sources

---